SYBX 1.42 (+3.65%)
US87166L1008BiotechnologyBiotechnology

Synlogic (SYBX) Stock Highlights

1.42 | +3.65%
2024-12-21 07:36:05
Synlogic Inc is a biopharmaceutical company focused on the discovery and development of Synthetic Biotic medicines which are designed to metabolize a toxic substance, compensate for missing or damaged metabolic pathways, or deliver combinations of therapeutic factors. Synthetic Biotic medicines are generated from the companys proprietary drug discovery and development platform, using Synthetic Biology and leveraging a reproducible, modular approach to develop beneficial microbes that perform or deliver critical therapeutic functions. Its key product candidate is SYNB1618, an oral therapy intended for the treatment of PKU, a rare metabolic disease in which an amino acid known as phenylalanine accumulates in the body as a result of genetic defects.

Statistics

Range Today
1.37 1.42
Volume Today 31.4K
Range 1 Year
1.22 5.12
Volume 1 Year 13.15M
Range 3 Year
0.23 5.71
Volume 3 Year 96.05M
Range 10 Year
0.23 77.07
Volume 10 Year 464.4M

Highlights

Market Capitalization 16.92M (micro)
Floating Shares 3.61M
Current Price 1.42
Price To Earnings -0.33
Price To Revenue -0.96
Price To Book 1.06
Earnings Per Share -4.82
Payout Ratio 0%

Performance

Latest +3.65%
1 Month +1.43%
3 Months -5.33%
6 Months -8.39%
1 Year -61.1%
3 Years -37.72%
5 Years -34.56%
10 Years -97.1%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.